Concepedia

Juliana E. Hidalgo‐Lόpez

JE

Statistics

Publications

8

Citations

227

H-Index

8

Active since

2017

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Juliana E. Hidalgo‐Lόpez is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and cancer research.

ORCID

Top concepts

Publications per year

2017–2024

8

Publications

8

A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

Lucia Masárová, Srđan Verstovšek, Juliana E. Hidalgo‐Lόpez et al. · Blood · 2018 · 69 citations · Full text

A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms

Rita Assi, Hagop M. Kantarjian, Guillermo Garcia‐Manero et al. · American Journal of Hematology · 2017 · 66 citations · Full text

Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value

Juliana E. Hidalgo‐Lόpez, Rashmi Kanagal‐Shamanna, Andres Quesada et al. · Cancer · 2018 · 24 citations · Full text

Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1

Andres Quesada, Guillermo Montalban‐Bravo, Rajyalakshmi Luthra et al. · Modern Pathology · 2020 · 19 citations · Full text

, , +8

Morphologic and Molecular Characteristics of De Novo AML With<i>JAK2</i>V617F Mutation

Juliana E. Hidalgo‐Lόpez, Rashmi Kanagal‐Shamanna, L. Jeffrey Medeiros et al. · Journal of the National Comprehensive Cancer Network · 2017 · 17 citations · Full text

1–5 of 8